“Impact of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors on Cardiovascular Events in Type 2 Diabetes” (2025) Indus Journal of Bioscience Research, 3(1), pp. 320–324. doi:10.70749/ijbr.v3i1.496.